| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Veids | Citi | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Valoda | EN | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statuss | Publicēts | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Versija | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Datums | 2015-05-15 15:59:33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Periods | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Versijas komentārs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Teksts |
Olainfarm Sells for 9.15 Million in April, Starts Exporting to Mongolia
Preliminary consolidated results of AS Olainfarm for April 2015 show that the group has made sales worth 9.15 million euros, which represents a reduction by 3% compared to April of last year. Sales to The Netherlands grew the most, as they increased by 800%. Sales to Kyrgyzstan increased by 129%. During April, the group also made significant shipments to Germany and started exporting of final dosage forms to Mongolia. Major sales markets of the group during April were Russia, Latvia, Ukraine, Belarus and The Netherlands.
Sales of pharmacy chain of SIA “Latvijas aptieka” in April 2015 was 1.4 million euros, which represents an increase by 11% compared to 2013. 58 pharmacies were during April. Sales of SIA “Silvanols” in April 2015 was 0.33 million euros, which represents an increase by 22% compared to 2014. In April SIA Silvanols started exporting to Austria and generally was selling its products in six European countries.
During four months of 2015, according to preliminary figures, consolidated sales of AS Olainfarm were 36.76 million euros, which represents an increase by 12% compared to similar period of 2014. The most rapid sales growth were achieved in the Netherlands, where sales grew by 203%. Sales to Kyrgyzstan grew by 129%, sales to Tajikistan grew by 88%, but sales to Kazakhstan grew by 58%. Major sales markets of AS Olainfarm in four months of 2015 were Russia, Latvia, Ukraine, The Netherlands and Belarus.
In four months of 2015, sales of pharmacy chain of SIA “Latvijas aptieka” was 5.6 million euros, which represents an increase by 10% compared to the same period one year ago. Sales of SIA Silvanols in four months of 2015 were 1.4 million euros, which represents and increase by 24% compared to first four months of 2014, when Silvanols’ sales equaled 1.13 million euros. During first four months of 2015, SIA Silvanols was exporting its products to 13 countries in two continents.
According to preliminary unconsolidated sales figures of AS Olainfarm, sales of the company during April 2015 were 8.08 million euros, which represents a reduction by 4% compared to the same period of 2014. The biggest sales increases were achieved in The Netherlands, where sales grew by 800%. Sales to Kyrgyzstan grew by 129%, sales to Turkmenistan grew by 37%, and significant shipments were made to Germany and exports started to Mongolia. Major sales markets of AS Olainfarm in April 2015 were Russia, Latvia, Ukraine, Belarus and The Netherlands. In total during April 2015, AS Olainfarm made its sales in 24 countries on three continents.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
April 2015, unconsolidated sales |
Share in total sales |
Changes to April 2014 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Russia |
43% |
-21% |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Latvia |
13% |
26% |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Ukraine |
12% |
-33% |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Belarus |
9% |
8% |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
The Netherlands |
7% |
800% |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Kazakhstan |
2% |
-11% |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Uzbekistan |
2% |
11% |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Germany |
2% |
NA |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Kyrgyzstan |
class= """""MsoNorma" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pielikumi |
|